GLO1 and melanoma: Following our earlier research on GLO1 overexpression observable during melanoma patient progression, we have now employed CRISPR/Cas 9-based GLO1 deletion and rescue expression, allowing stringent genetic target modulation as examined in A375 human malignant melanoma cells.